Alternative meat and dairy companies are raking in investment dollars
Caroline Bushnell, GFI’s vice president of Corporate Engagement, discusses why there’s room for both established and new players in the growing field of alternative proteins.
Caroline Bushnell, GFI’s vice president of Corporate Engagement, discusses why there’s room for both established and new players in the growing field of alternative proteins.
GFI urges FDA to establish principles for modernizing food standards that account for all foods. Learn why doing so is vital to FDA’s goal of supporting innovation.
GFI's Bruce Friedrich spells out that among the many steps we could take to lower the risk of the next pandemic, perhaps the most effective would be to stop farming animals for meat.
GFI’s comment requests that the Committee work to establish an interagency Alternative Protein Initiative. Learn why doing so would support rural America.
Jamie Harris of the Sentience Institute speaks with Dr. Elliot Swartz about the science of plant-based and cultivated meat, technical barriers to scaling, and professional opportunities in alternative proteins.
Seafood is difficult to make without animals, notes GFI's Jen Lamy. But some companies are betting on new technologies and customers to overcome the challenges.
Corporate Engagement’s Caroline Bushnell explains the surge of investor confidence in alternative proteins that is being fuelled by increasing consumer interest.
The Breakthrough Institute highlights the importance of public support for alternative proteins and suggests ways that Congress could support continued research and development.
GFI’s comment urges the Committee to dedicate stimulus funds to support alternative proteins. Learn why doing so would help create a resilient and sustainable food supply.
GFI’s supplement highlights market developments since submitting its Citizen Petition. Learn why the developments demonstrate a need for clarity from FDA.